Cynosure Q2: Continued Growth and Profitability
Quarterly revenues at Cynosure, a developer of laser-based aesthetic systems, grew 30% year-over-year, from $30.1 million in Q2 2007 to $39.2 million in the most […]
Articles by Doug Cress
Cepheid: Q2 Revenues Up 55 Percent, Loss Widens
On Thursday, Cepheid reported $42.1 million in quarterly revenues, a 55% jump from the $27.2 million reported in the same period last year. Growth has […]
AngioDynamics Reports Better Than Expected Quarterly Profit
Regular readers will know I’m bullish on AngioDynamics. Yesterday, the Queensbury NY-based company reported better than expected quarterly profit, buoyed by strong sales in its […]
[Video] New Developments at Chembio Diagnostics
Chembio Diagnostics develops, manufactures and markets rapid, point-of-care tests for the detection of HIV 1/ 2, Chagas and Sickle Cell disease as well as other […]
Tattoo Regret Could be a Boon for Device Manufacturers
I’ll never get a tattoo. Call me conservative, but the thought of having an ink-based design etched permanently into my skin is more than the […]
NxStage Releases New Patient Data; Remains Committed to Top Line Growth
NxStage Medical, a Lawrence, MA company that makes dialysis systems, has released new end-stage renal-disease (ESRD) patient data. The information was derived from a registry […]
Cynosure’s Smartlipo Gets CE Mark; U.S. Sales to Impact Second Quarter Results
For the morbidly obese (BMI > 40), liposuction is not really an option. But for a much broader set of women – those with fat […]
Q2 Earnings Report: ICU Medical
San Clemente, CA-based ICU Medical nearly doubled net income despite stagnating top line growth and a poor-performing critical care business. Second quarter revenue was $48.6 […]
One in Four Americans Obese
One in four Americans is now obese, says the CDC. While it’s less than welcome news, you can hardly say it’s surprising – we’ve been […]
Elemé Medical Raises $18 Million to Commercialize Cellulite Treatment
Treatment for cellulite is a healthcare holy grail – second only (in this author’s opinion) to a cure for male pattern baldness. As the bane […]